Medical Cannabis
Science-led insight on therapeutic use, formulations, and clinical best practice.
Medical Cannabis · page 7
- Clinical Research
Veterans and Medical Cannabis: Can Private Clinics Fill NHS Treatment Gaps?
The UK’s health service is fighting to keep its head above water, yet with a record-breaking winter flu pandemic sweeping the nation, and a looming industrial action set to see thousands of resident doctors walk out later this week, the water level is rising rapidly.
- Clinical Research
‘Blockbuster’ Cannabis Drug To Be Released in 2026
Findings from the successful trials of a new, multi-compound, cannabis medicine look set to deliver a major breakthrough for the world’s half-a-billion chronic low back pain (CLB) sufferers.
- Medical Cannabis
Glass Pharms Announces New UK Supply Deals as it launches Premium Range
Glass Pharms, the UK-based cultivator of medical cannabis flower, has announced a supply agreement with Integro Clinic & IPS Pharmacy to provide them with a new premium range of Glass Pharms-branded CBPMs made with domestically grown flower cultivated at the Glass Pharms facility.
- Industry Trends
In the UK’s Medical Cannabis Market, the Winner Takes All
Earlier this week, we looked at the dramatic shifts in the UK medical cannabis flower market over the last three years.
- Industry Trends
What Is Really Going on in the UK’s Medical Cannabis Market? (New 2025 Data Analysis)
The UK’s medical cannabis industry has nearly tripled in size since 2022, according to new Freedom of Information data offering the most comprehensive look into what is being prescribed in the UK to date.
- Industry Trends
First Practical Medical Cannabis Oil Dosing Guide Published for UK Clinicians
Originally published on Cannabis Health The Medical Cannabis Clinicians Society (MCCS) has published what it describes as a crucial step forward for standardised prescribing in the UK, a comprehensive guide establishing evidence-based dosing protocols for cannabis oils.
- CBD Market
Medicare CBD Coverage Proposed, But Federal Ban Threatens Entire Industry
Cannabis stocks enjoyed another spike last week following reports that the Centers for Medicare & Medicaid Services is preparing to authorise insurance coverage for CBD products under certain Medicare programs, even as the same products face an existential threat from recently passed federal legislation.
- Clinical Research
Cannabis Health Symposium 2025 – Key Takeaways Part 2
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the UK.
- Clinical Research
Cannabis Health Symposium 2025 – Key Takeaways Part 1
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium.
- Cultivation
There’s No UK Cannabis Industry Without UK Cultivation
The UK economic growth faces a paradox of two seemingly opposing pressures, yet both may be resolved by moving in the same direction.
- Clinical Research
How to Read a Cannabis Research Paper
Why Reading Research Matters The volume of cannabis research has never been higher, but not all studies are created equal.
- Medical Cannabis
Patients Make History at First Educational Event on Cannabis-Based Medicines in London
First published on Cannabis Health Medical cannabis patients made history in London with a first-of-its-kind, patient-led education event focused on cannabis-based medicines, hosted at the Charterhouse.
